AtriCure Reports First Quarter 2019 Financial Results


MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2019 financial results. “We had a good start to the year fueled by solid performance across our business in the first quarter,” said Mike Carrel, President and Chief Executive Officer of AtriCure. “With outstanding Appendage Management performance, combined with the cryoSPHERETM probe launch for pe